Other formats:
BibTeX
LaTeX
RIS
@article{1479522,
author = {Heissigerová, Jarmila and Callanan, David and de Smet, Marc and Srivastava, Sunil K. and Karkanová, Michala and GarciaandGarcia, Olga and Kadayifcilar, Sibel},
doi = {http://dx.doi.org/10.1016/j.ophtha.2018.09.044},
keywords = {Sarilumab, rear uveitis, anti-interleukin-6 receptor antibody},
language = {eng},
issn = {0161-6420},
journal = {Ophthalmology},
title = {Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial},
url = {http://dx.doi.org/10.1016/j.ophtha.2018.09.044},
year = {2019}
}
TY - JOUR
ID - 1479522
AU - Heissigerová, Jarmila - Callanan, David - de Smet, Marc - Srivastava, Sunil K. - Karkanová, Michala - Garcia-Garcia, Olga - Kadayifcilar, Sibel
PY - 2019
TI - Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial
JF - Ophthalmology
SP - 1549-4713
EP - 1549-4713
SN - 01616420
KW - Sarilumab, rear uveitis, anti-interleukin-6 receptor antibody
UR - http://dx.doi.org/10.1016/j.ophtha.2018.09.044
L2 - http://dx.doi.org/10.1016/j.ophtha.2018.09.044
N2 - To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).Subcutaneous sarilumab may provide clinical benefits in the management of NIU of the posterior segment, especially in eyes with uveitic macular edema.
ER -
HEISSIGEROVÁ, Jarmila, David CALLANAN, Marc DE SMET, Sunil K. SRIVASTAVA, Michala KARKANOVÁ, Olga GARCIA-GARCIA and Sibel KADAYIFCILAR. Efficacy and Safety of Sarilumab for Noninfectious Uveitis of Posterior Segment: Outcomes From the Phase 2 SATURN Trial. \textit{Ophthalmology}. 2019, p.~1549-4713. ISSN~0161-6420. Available from: https://dx.doi.org/10.1016/j.ophtha.2018.09.044.
|
